Related Experiment Video
Updated: May 10, 2026

Functional Neuroimaging Using Ultrasonic Blood-brain Barrier Disruption and Manganese-enhanced MRI
Published on: July 12, 2012
A method for conducting functional MRI studies in alert nonhuman primates: initial results with opioid agonists in
Marc J Kaufman1, Amy C Janes, Blaise deB Frederick
1McLean Imaging Center, McLean Hospital, Belmont, MA 02478, USA. kaufman@mclean.harvard.edu
Abstract:
Functional MRI (fMRI) has emerged as a powerful technique for assessing neural effects of psychoactive drugs and other stimuli. Several experimental approaches have been developed to use fMRI in anesthetized and awake animal subjects, each of which has its advantages and complexities. We sought to assess whether one particular method to scan alert postanesthetized animals can be used to assess fMRI effects of opioid agonists. To date, the use of fMRI as a method to compare pharmacological effects of opioid drugs has been limited. Such studies are important because mu and kappa opioid receptor agonists produce distinct profiles of behavioral effects related both to clinically desirable endpoints (e.g., analgesia) and to undesirable effects (e.g., abuse potential). This study sought to determine whether we could use our fMRI approach to compare acute effects of behaviorally equipotent (3.2 μg/kg) intravenous doses of fentanyl and U69,593 (doses that do not affect cardiorespiratory parameters). Scans were acquired in alert male cynomolgus macaques acclimated to undergo fMRI scans under restraint, absent excessive stress hormone increases. These opioid agonists activated bilateral striatal and nucleus accumbens regions of interest. At the dose tested, U69,593 induced greater left nucleus accumbens BOLD activation than fentanyl, while fentanyl activated left dorsal caudate nucleus more than U69,593. Our results suggest that our fMRI approach could be informative for comparing effects of opioid agonists.
Insights
Functional MRI (fMRI) can compare opioid agonist effects in alert macaques. This study shows distinct brain activations for fentanyl and U69,593, suggesting fMRI
Area of Science:
- Neuroscience
- Pharmacology
- Medical Imaging
Background:
- Functional MRI (fMRI) is a key tool for studying drug effects on the brain.
- Comparing opioid receptor agonists is crucial due to their varied effects, including analgesia and abuse potential.
- Previous fMRI studies on opioid drug comparisons are limited.
Purpose of the Study:
- To evaluate an fMRI method for assessing opioid agonist effects in alert, postanesthetized animals.
- To compare the acute neural effects of fentanyl and U69,593 using fMRI.
- To determine if fMRI can differentiate the brain activation patterns of mu and kappa opioid receptor agonists.
Main Methods:
- Utilized fMRI in alert male cynomolgus macaques acclimated to scanning.
- Administered behaviorally equipotent intravenous doses of fentanyl and U69,593.
- Analyzed Blood-Oxygen-Level-Dependent (BOLD) activation in striatal and nucleus accumbens regions.
Main Results:
- Both fentanyl and U69,593 activated bilateral striatal and nucleus accumbens regions.
- U69,593 showed greater left nucleus accumbens BOLD activation compared to fentanyl.
- Fentanyl induced greater left dorsal caudate nucleus activation than U69,593.
Conclusions:
- The fMRI approach is effective for comparing the neural effects of opioid agonists in alert animals.
- Distinct patterns of brain activation were observed between fentanyl and U69,593.
- This method holds promise for future research into opioid pharmacology and abuse potential.

